Clinical indications for coronary artery calcium scoring in asymptomatic patients: Expert consensus statement from the Society of Cardiovascular Computed Tomography

Journal of Cardiovascular Computed Tomography

Volumn 11, Issue 2, 2017, Pages 157-168

  Hecht, Harvey ^a   Blaha, Michael J ^b   Berman, Daniel S ^c   Nasir, Khurram ^d   Budoff, Matthew ^e   Leipsic, Jonathon ^f   Blankstein, Ron ^g   Narula, Jagat ^a   Rumberger, John ^h   Shaw, Leslee J ⁱ  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^e LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g HARVARD MEDICAL SCHOOL   (United States)

^h Princeton Longevity Center   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery calcium scoring in asymptomatic patients

Indexed keywords

ARTICLE; ASYMPTOMATIC DISEASE; CONSENSUS; CORONARY ARTERY CALCIUM SCORE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; MYOCARDIAL PERFUSION IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SHARED DECISION MAKING; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; CLINICAL DECISION MAKING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; PREDICTIVE VALUE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STANDARDS; VASCULAR CALCIFICATION;

ASYMPTOMATIC DISEASES; CLINICAL DECISION-MAKING; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CONSENSUS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DECISION SUPPORT TECHNIQUES; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION;

EID: 85014541435     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2017.02.010     Document Type: Article

References (140)

1. 1 Rumberger, J.A., Brundage, B.H., Rader, D.J., Kondos, G., Electron beam CT coronary calcium scanning: a review and guidelines for use in asymptomatic individuals. Mayo Clin Proc 74 (1999), 243–252.
2. 2 Sangiorgi, G., Rumberger, J.A., Severson, A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using non-decalcifying methodology. J Am Coll Cardiol 31 (1998), 126–133.
3. 3 Rumberger, J.A., Simons, D.B., Fitzpatrick, L.A., Sheedy, P.F., Schwartz, R.S., Coronary artery calcium areas by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 92 (1995), 2157–2162.
4. 4 O'Rourke, R.A., Brundage, B.H., Froelicher, V.F., et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 36 (2000), 326–340.
5. 5 Pletcher, M.J., Tice, J.A., Pignone, M., Browner, W.S., Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 164 (2004), 1285–1292.
6. 6 Greenland, P., Bonow, R.O., Brundage, B.H., et al. American College of cardiology foundation clinical expert consensus Task F, society of atherosclerosis I, prevention and society of cardiovascular computed T. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of cardiology foundation clinical expert consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the society of atherosclerosis imaging and prevention and the society of cardiovascular computed tomography. J Am Col Cardiol 49 (2007), 378–402.
7. 7 Greenland, P., Alpert, J.S., Beller, G.A., et al., American College of Cardiology F and American Heart A. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. 2010 J Am Coll Cardiol 56 (2010), e50–103.
8. 8 Perrone-Filardi, P., Achenbach, S., Mohlenkamp, S., et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the working group on nuclear cardiology and cardiac CT of the European society of cardiology. Eur heart J 32 (2011), 1986–1993 1993a, 1993b.
9. 9 Peters, S.A., den Ruijter, H.M., Bots, M.L., Moons, K.G., Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 98 (2012), 177–184.
10. 10 Mamudu, H.M., Paul, T.K., Veeranki, S.P., Budoff, M., The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis 236 (2014), 338–350.
11. 11 Kavousi, M., Desai, C.S., Ayers, C., et al. Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis. JAMA 316 (2016), 2126–2134.
12. 12 Nasir, K., Clouse, M., Role of nonenhanced multidetector CT coronary artery calcium testing in asymptomatic and symptomatic individuals. Radiology 264 (2012), 637–649.
13. 13 Blaha, M.J., Silverman, M.G., Budoff, M.J., Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients. Circ Cardiovasc Imaging 7 (2014), 398–408.
14. 14 Kianoush, S., Al Rifai, M., Cainzos-Achirica, M., et al. An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction. Curr Atheroscler Rep, 18, 2016, 13.
15. 15 Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al. American College of cardiology/American heart association Task Force on practice guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of cardiology/American heart association Task Force on practice guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
16. 16 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., et al., American College of cardiology/American heart association Task Force on practice G. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of cardiology/American heart association Task Force on practice guidelines. J Am Coll Cardiol 63 (2014), 2889–2934.
17. 17 Amin, N.P., Martin, S.S., Blaha, M.J., Nasir, K., Blumenthal, R.S., Michos, E.D., Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. J Am Coll Cardiol 63 (2014), 2789–2794.
18. 18 Blaha, M.J., Blumenthal, R.S., Risk factors: new risk-assessment guidelines-more or less personalized?. Nat Rev Cardiol 11 (2014), 136–137.
19. 19 Cainzos-Achirica, M., Desai, C.S., Wang, L., et al. Pathways forward in cardiovascular disease prevention one and a half years after publication of the 2013 ACC/AHA cardiovascular disease prevention guidelines. Mayo Clin Proc 90 (2015), 1262–1271.
20. 20 US Preventive Services Task ForceBibbins-Domingo, K., Grossman, D.C., Curry, S.J., et al. Statin use for the primary prevention of cardiovascular disease in adults: US preventive Services Task Force recommendation statement. JAMA 316 (2016), 1997–2007.
21. 21 Detrano, R., Guerci, A.D., Carr, J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Eng J Med 358 (2008), 1336–1345.
22. 22 Hoffmann, U., Massaro, J.M., D'Agostino, R.B. Sr., Kathiresan, S., Fox, C.S., O'Donnell, C.J., Cardiovascular event prediction and risk reclassification by coronary, Aortic, and valvular calcification in the Framingham heart study. J Am Heart Assoc, 2016, 5.
23. 23 Paixao, A.R., Ayers, C.R., El Sabbagh, A., et al. Coronary artery calcium improves risk classification in younger populations. JACC Cardiovasc Imaging 8 (2015), 1285–1293.
24. 24 Baber, U., Mehran, R., Sartori, S., et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol 65 (2015), 1065–1074.
25. 25 Erbel, R., Mohlenkamp, S., Moebus, S., et al., Heinz Nixdorf Recall Study Investigative G. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardio 56 (2010), 1397–1406.
26. 26 Budoff, M.J., Shaw, L.J., Liu, S.T., et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49 (2007), 1860–1870.
27. 27 Shaw, L.J., Giambrone, A.E., Blaha, M.J., et al. Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study. Ann Int Med 163 (2015), 14–21.
28. 28 Blaha, M.J., Whelton, S.P., Al Rifai, M., et al. Rationale and design of the coronary artery calcium consortium: a multicenter cohort study. J Cardiovasc Comput Tomogr, 2016 Nov 11 [Epub ahead of print].
29. 29 Yeboah, J., McClelland, R.L., Polonsky, T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308 (2012), 788–795.
30. 30 Tota-Maharaj, R., Blaha, M.J., McEvoy, J.W., et al. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old. Eur Heart J 33 (2012), 2955–2962.
31. 31 Nasir, K., Rubin, J., Blaha, M.J., et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging 5 (2012), 467–473.
32. 32 Yeboah, J., Young, R., McClelland, R.L., et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol 67 (2016), 139–147.
33. 33 Goel, R., Garg, P., Achenbach, S., et al. Coronary artery calcification and coronary atherosclerotic disease. Cardiol Clin 30 (2012), 19–47.
34. 34 Kelkar, A.A., Schultz, W.M., Khosa, F., et al. Long-term prognosis after coronary artery calcium scoring among low-intermediate risk women and men. Circ Cardiovasc Imaging, 9, 2016, e003742.
35. 35 Raggi, P., Shaw, L.J., Berman, D.S., Callister, T.Q., Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43 (2004), 1663–1669.
36. 36 Malik, S., Budoff, M.J., Katz, R., et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care 34 (2011), 2285–2290.
37. 37 Budoff, M.J., Raggi, P., Beller, G.A., et al. Imaging council of the American College of cardiology. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the imaging council of the American College of cardiology. JACC Cardiovasc Imaging 9 (2016), 176–192.
38. 38 Tota-Maharaj, R., Blaha, M.J., Blankstein, R., et al. Association of coronary artery calcium and coronary heart disease events in young and elderly participants in the multi-ethnic study of atherosclerosis: a secondary analysis of a prospective, population-based cohort. Mayo Clin Proc 89 (2014), 1350–1359.
39. 39 McEvoy, J.W., Blaha, M.J., Rivera, J.J., et al. Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc imaging 5 (2012), 1037–1045.
40. 40 Schulman-Marcus, J., Valenti, V., Hartaigh, B.O., et al. Prognostic utility of coronary artery calcium scoring in active smokers: a 15-year follow-up study. Int J Cardiol 177 (2014), 581–583.
41. 41 Graham, G., Blaha, M.J., Budoff, M.J., et al. Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. Atherosclerosis 225 (2012), 432–437.
42. 42 Erbel, R., Lehmann, N., Möhlenkamp, S., et al., Heinz Nixdorf Recall Study Investigators. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf recall study. Hypertension 59 (2012), 44–53.
43. 43 Martin, S.S., Blaha, M.J., Blankstein, R., et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation 129 (2014), 77–86.
44. 44 Patel, J., Al Rifai, M., Blaha, M.J., et al. Coronary artery calcium improves risk assessment in adults with a family history of premature coronary heart disease: results from multiethnic study of atherosclerosis. Circ Cardiovasc imaging, 8, 2015, e003186.
45. 45 Shemesh, J., Motro, M., Morag-Koren, N., Konen, E., Grossman, E., Relation of coronary artery calcium to cardiovascular risk in patients with combined diabetes mellitus and systemic hypertension. Am J Cardiol 109 (2012), 844–850.
46. 46 Nakanishi, R., Li, D., Blaha, M.J., et al. The relationship between coronary artery calcium score and the long-term mortality among patients with minimal or absent coronary artery risk factors. Int J Cardiol 185 (2015), 275–281.
47. 47 Blaha, M.J., Cainzos-Achirica, M., Greenland, P., et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA). Circulation 133 (2016), 849–858.
48. 48 Blaha, M., Budoff, M.J., Shaw, L.J., et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2 (2009), 692–700.
49. 49 Budoff, M.J., McClelland, R.L., Nasir, K., et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 158 (2009), 554–561.
50. 50 Kelkar, A.A., Schultz, W.M., Khosa, F., et al. Long-term prognosis after coronary artery calcium scoring among low-intermediate risk women and men. Circ Cardiovasc Imaging, 9, 2016, e003742.
51. 51 Whelton, S.P., Silverman, M.G., McEvoy, J.W., et al. Predictors of long-term healthy arterial aging: coronary artery calcium nondevelopment in the MESA study. JACC Cardiovasc Imaging 8 (2015), 1393–1400.
52. 52 Handy, C.E., Desai, C.S., Dardari, Z.A., et al. The association of coronary artery calcium with noncardiovascular disease: the multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging 9 (2016), 568–576.
53. 53 Saleem, Y., DeFina, L.F., Radford, N.B., et al. Association of a favorable cardiovascular health profile with the presence of coronary artery calcification. Circ Cardiovasc Imaging, 8, 2014.
54. 54 Valenti, V., Ó Hartaigh, B., Heo, R., et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging 8 (2015), 900–909.
55. 55 Polonsky, T.S., McClelland, R.L., Jorgensen, N.W., et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303 (2010), 1610–1616.
56. 56 Pencina, M.J., D'Agostino, R.B. Sr., D'Agostino, R.B., Vasan, R.S., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics Med 27 (2008), 157–172.
57. 57 McEvoy, J.W., Diamond, G.A., Detrano, R.C., et al. Risk and the physics of clinical prediction. Am J Cardiol 113 (2014), 1429–1435.
58. 58 Ridker, P.M., Cook, N.R., Statins: new American guidelines for prevention of cardiovascular disease. Lancet 382 (2013), 1762–1765.
59. 59 DeFilippis, A.P., Young, R., Carrubba, C.J., et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 162 (2015), 266–275.
60. 60 Pursnani, A., Massaro, J.M., D'Agostino, R.B. Sr., O'Donnell, C.J., Hoffmann, U., Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA 314 (2015), 134–141.
61. 61 Cook, N.R., Ridker, P.M., Calibration of the pooled cohort Equations for atherosclerotic cardiovascular disease: an update. Ann Intern Med 165 (2016), 786–794.
62. 62 Rana, J.S., Tabada, G.H., Solomon, M.D., et al. Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. J Am Coll Cardiol 67 (2016), 2118–2130.
63. 63 DeFilippis, A.P., Young, R., McEvoy, J.W., et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. Eur Heart J, 2016 Jul 19. [Epub ahead of print].
64. 64 Cook, N.R., Ridker, P.M., Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the women's health study. JAMA Intern Med 174 (2014), 1964–1971.
65. 65 Nasir, K., Bittencourt, M.S., Blaha, M.J., et al. Implications of coronary artery calcium testing among statin candidates according to American College of cardiology/American heart association cholesterol management guidelines: MESA (Multi-Ethnic study of atherosclerosis). J Am Coll Cardiol 66 (2015), 1657–1668.
66. 66 Mahabadi, A.A., Möhlenkamp, S., Lehmann, N., et al., Investigative group of the Heinz Nixdorf Recall study. CAC score improves coronary and CV risk assessment above statin indication by ESC and AHA/ACC primary prevention guidelines. JACC Cardiovasc Imaging, 2016 Sep 16 [Epub ahead of print].
67. 67 Mortensen, M.B., Fuster, V., Muntendam, P., et al. A simple disease-guided approach to personalize ACC/AHA-recommended statin Allocation in elderly people: the BioImage study. J Am Coll Cardiol 68 (2016), 881–891.
68. 68 Yeboah, J., Polonsky, T.S., Young, R., et al. Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of cardiology/American heart association cholesterol guidelines. Circulation 132 (2015), 916–922.
69. 69 Oshima Lee, E., Emanuel, E.J., Shared decision making to improve care and reduce costs. N Engl J Med 368 (2013), 6–8.
70. 70 Martin, S.S., Sperling, L.S., Blaha, M.J., et al. Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA guidelines. J Am Coll Cardiol 65 (2015), 1361–1368.
71. 71 Desai, C.S., Martin, S.S., Blumenthal, R.S., Non-cardiovascular effects associated with statins. BMJ, 349, 2014, g3743.
72. 72 Swiger, K.J., Manalac, R.J., Blumenthal, R.S., Blaha, M.J., Martin, S.S., Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects. Mayo Clin Proc 88 (2013), 1213–1221.
73. 73 Einstein, A.J., Berman, D.S., Min, J.K., et al. Patient-centered imaging: shared decision making for cardiac imaging procedures with exposure to ionizing radiation. J Am Coll Cardiol 63 (2014), 1480–1489.
74. 74 Budoff, M.J., Rader, D.J., Reilly, M.P., et al., CRIC Study Investigators. Relationship of estimated GFR and coronary artery calcification in the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis 50 (2011), 519–526.
75. 75 Giles, J.T., Szklo, M., Post, W., et al. Coronary arterial calcification in rheumatoid arthritis: comparison with the multi-ethnic study of atherosclerosis. Arthritis Res Ther, 11, 2009, R36.
76. 76 Asanuma, Y., Oeser, A., Shintani, A.K., et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003), 2407–2415.
77. 77 Hsue, P.Y., Squires, K., Bolger, A.F., et al. Working Group 4 Screening and assessment of coronary heart disease in HIV Infected patients. Circulation 118 (2008), e41–e47.
78. 78 Shah, N.P., Cainzos-Achirica, M., Feldman, D.I., et al. Cardiovascular disease prevention in men with vascular erectile dysfunction: the view of the preventive cardiologist. Am J Med 129 (2016), 251–259.
79. 79 Ali, S.S., Oni, E.T., Warraich, H.J., et al. Systematic review on noninvasive assessment of subclinical cardiovascular disease in obstructive sleep apnea: new kid on the block!. Sleep Med Rev 18 (2014), 379–391.
80. 80 Blaha, M.J., Budoff, M.J., DeFilippis, A.P., et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 378 (2011), 684–692.
81. 81 Miedema, M.D., Duprez, D.A., Misialek, J.R., et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes 7 (2014), 453–460.
82. 82 Kalia, N.K., Miller, L.G., Nasir, K., Blumenthal, R.S., Agrawal, N., Budoff, M.J., Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis 185 (2006), 394–399.
83. 83 Rozanski, A., Gransar, H., Shaw, L.J., et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 57 (2011), 1622–1632.
84. 84 Mitchell, S., Roso, S., Samuel, M., Pladevall-Vila, M., Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies. BMC Cardiovasc Dis, 16, 2016, 74.
85. 85 Ho, P.M., Bryson, C.L., Rumsfeld, J.S., Medication adherence: its importance in cardiovascular outcomes. Circulation 119 (2009), 3028–3035.
86. 86 Ockene, J.K., Schneider, K.L., Lemon, S.C., Ockene, I.S., Can we improve adherence to preventive therapies for cardiovascular health?. Circulation 124 (2011), 1276–1282.
87. 87 Mamudu, H.M., Paul, T.K., Veeranki, S.P., Budoff, M., The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis 236 (2014), 338–350.
88. 88 Taylor, A.J., Bindeman, J., Feuerstein, I., et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol 51 (2008), 1337–1341.
89. 89 O'Malley, P.G., Feuerstein, I.M., Taylor, A.J., Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA 289 (2003), 2215–2223.
90. 90 McEvoy, J.W., Blaha, M.J., Defilippis, A.P., et al. Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 56 (2010), 1613–1622.
91. 91 Oudkerk, M., Stillman, A.E., Halliburton, S.S., et al. European society of cardiac R and North American society for cardiovascular I. Coronary artery calcium screening: current status and recommendations from the European society of cardiac Radiology and North American society for cardiovascular imaging. Eur Radiol 18 (2008), 2785–2807.
92. 92 Puri, R., Nicholls, S.J., Shao, M., et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 65 (2015), 1273–1282.
93. 93 Hong, M.K., Park, D.W., Lee, C.W., et al. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. JACC Cardiovasc Interv 2 (2009), 679–688.
94. 94 Tian, J., Gu, X., Sun, Y., et al. Effect of statin therapy on the progression of coronary atherosclerosis. BMC Cardiovasc Disord, 12, 2012 Sep 1, 70 doi: 1.1186/1471-2261-12-70.
95. 95 Nozue, T., Yamamoto, S., Tohyama, S., et al. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Am Heart J 163 (2012), 191–199.
96. 96 Park, S.J., Kang, S.J., Ahn, J.M., et al. Han KH2, Park SW2. Effect of statin treatment on modifying plaque composition: a double-blind, randomized study. J Am Coll Cardiol 67 (2016), 1772–1783.
97. 97 Raggi, P., Cooil, B., Shaw, L.J., et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 92 (2003), 827–829.
98. 98 Raggi, P., Callister, T.Q., Shaw, L.J., Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol lowering therapy. Arterioscler Thromb Vasc Biol 24 (2004), 1–7.
99. 99 Budoff, M.J., Hokanson, J.E., Nasir, K., et al. Progression of coronary artery calcium predicts all cause mortality. J Am Coll Cardiol Img 3 (2010), 1229–1236.
100. 100 Budoff, M.J., Young, R., Lopez, V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 61 (2013), 1231–1239.
101. 101 Budoff, M.J., Young, R., Lopez, V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 61 (2013), 1231–1239.
102. 102 Wong, N.D., Nelson, J.C., Granston, T., et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging 5 (2012), 358–366.
103. 103 Kiramijyan, S., Ahmadi, N., Isma'eel, H., et al. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. Am J Cardiol 111 (2013), 356–361.
104. 104 Min, J.K., Lin, F.Y., Gidseg, D.S., et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the “warranty period” for remaining normal?. J Am Coll Cardiol 55 (2010), 1110–1117.
105. 105 Al Rifai, M., Cainzos-Achirica, M., Blaha, M.J., Establishing the warranty of a coronary artery calcium score of zero. Atherosclerosis 238 (2015), 1–3.
106. 106 Silverman, M.G., Harkness, J.R., Blankstein, R., et al. Baseline subclinical atherosclerosis burden and distribution are associated with frequency and mode of future coronary revascularization: multi-ethnic study of atherosclerosis. JACC Cardiovasc imaging 7 (2014), 476–486.
107. 107 Hausleiter, J., Meyer, T., Hermann, F., et al. Estimated radiation dose associated with cardiac CT angiography. JAMA 301 (2009), 500–507.
108. 108 Kurata, A., Dharampal, A., Dedic, A., et al. Impact of iterative reconstruction on CT coronary calcium quantification. Eur Radiol 23 (2013), 3246–3252.
109. 109 Gebhard, C., Fiechter, M., Fuchs, T.A., et al. Coronary artery calcium scoring: influence of adaptive statistical iterative reconstruction using 64-MDCT. Interj Cardiol 167 (2013), 2932–2937.
110. 110 Hecht, H.S., Siqueira, M.A., Cham, M., et al. Low- vs.standard-dose coronary artery calcium scanning. Eur Heart J Cardiovasc Imaging 16 (2015), 358–363.
111. 111 Messerli, M., Rengier, F., Desbiolles, L., et al. Impact of advanced modeled iterative reconstruction on coronary artery calcium quantification. Acad Radiol 23 (2016), 1506–1512.
112. 112 Nakazato, R., Dey, D., Gutstein, A., et al. Coronary artery calcium scoring using a reduced tube voltage and radiation dose protocol with dual-source computed tomography. J Cardiovasc Comput Tomogr 3 (2009), 394–400.
113. 113 Marwan, M., Mettin, C., Pflederer, T., et al. Very low-dose coronary artery calcium scanning with high-pitch spiral acquisition mode: comparison between 120-kV and 100-kV tube voltage protocols. J Cardiovasc Comput Tomogr 7 (2013), 32–38.
114. 114 Moyer, V.A., USPSTF. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Int Med 160 (2014), 330–338.
115. 115 http://www.cms.gov/medicare-coverage-database/details/ncadetails.aspx?NCAId.274&NcaName.Screening.for.Lung.Cancer.with.Low.Dose.Computed.Tomography. (LDCT)%26MEDCACId.68%26IsPopup.y&. National Coverage Analysis (NCA) for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N).
116. 116 Berrington de Gonzalez, A., Mahesh, M., Kim, K.P., et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Int Med 169 (2009), 2071–2077.
117. 117 Polonsky, T.S., Greenland, P., Coronary artery calcium scores using nongated computed tomography. What to do with incidental results?. Circ Cardiovasc Imaging 6 (2013), 494–9528.
118. 118 http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/NRDR/Lung%20Cancer%20Screening%20Practice%20Registry/Exam%20Form.pdf.
119. 119 Kim, S.M., Chung, M.J., Lee, K.S., Choe, Y.H., Yi, C.A., Choe, B.K., Coronary calcium screening using low-dose lung cancer screening: effectiveness of MDCT with retrospective reconstruction. Am J Roentgen 190 (2008), 917–922.
120. 120 Wu, M.T., Yang, P., Huang, Y.L., et al. Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: concordance study with dedicated cardiac CT. Am J Roentgen 190 (2008), 923–928.
121. 121 Budoff, M.J., Nasir, K., Kinney, G.L., et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort. J Cardiovasc Comput Tomogr 5 (2011), 113–118.
122. 122 Xie, X., Zhao, Y., de Bock, G.H., et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging 6 (2013), 514–521.
123. 123 Mets, O.M., Vliegenthart, R., Gondrie, M.J., et al. Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc imaging 6 (2013), 899–907.
124. 124 Chiles, C., Duan, F., Gladish, G.W., et al. Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods. Radiology 276 (2015), 82–90.
125. 125 Shemesh, J., Henschke, C.I., Shaham, D., et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 257 (2010), 541–548.
126. 126 Hecht, H.S., Cronin, P., Blaha, M.J., et al. SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the society of cardiovascular computed tomography and society of thoracic radiology. 2016 Nov 10. [Epub ahead of print] J Cardiovasc Comput Tomogr, 2016.
127. 127 Margolis, L.S.M., Hecht, H.S., Kotkin, S., Narula, J., Yankelevitz, D., Henschke, C., Digital mammography and screening for coronary artery disease. JACC Cardiovasc imaging 9 (2016), 350–360.
128. 128 Berman, D.S., Wong, N.D., Gransar, H., et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 44 (2004), 923–930.
129. 129 Einstein, A.J., Johnson, L.L., Bokhari, S., et al. Agreement of visual estimation of coronary artery calcium from low-dose CT attenuation correction scans in hybrid PET/CT and SPECT/CT with standard Agatston score. J Am Coll Cardiol 56 (2010), 1914–1921.
130. 130 Berman, D.S., Kang, X., Slomka, P.J., et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 14 (2007), 521–528.
131. 131 Budoff, M.J., Diamond, G.A., Raggi, P., et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 105 (2002), 1791–1796.
132. 132 Engbers, E.M., Timmer, J.R., Ottervanger, J.P., Mouden, M., Knollema, S., Jager, P.L., Prognostic value of coronary artery calcium scoring in addition to single-photon emission computed tomographic myocardial perfusion imaging in symptomatic patients. Circ Cardiovasc Imaging, 9, 2016.
133. 133 Chang, S.M., Nabi, F., Xu, J., et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 54 (2009), 1872–1882.
134. 134 Uretsky, S., Cohen, R., Argulian, E., et al. Combining stress-only myocardial perfusion imaging with coronary calcium scanning as a new paradigm for initial patient work-up: an exploratory analysis. J Nucl Cardiol 22 (2015), 89–97.
135. 135 Bybee, K.A., Lee, J., Markiewicz, R., et al. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol 17 (2010), 188–196.
136. 136 Blankstein, R., Dorbala, S., Adding calcium scoring to myocardial perfusion imaging: does it alter physicians' therapeutic decision making?. J Nucl Cardiol 17 (2010), 168–171.
137. 137 Shaw, L.J., Merz, C.N., Bittner, V., et al., Investigators. Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the national institutes of health, national heart, lung and blood institute-sponsored Women's ischemia syndrome evaluation (WISE). J Womens Health (Larchmt) 17 (2008), 1081–1092.
138. 138 http://www.who.int/gho/publications/en/(2012statistics).
139. 139 Hlatky, M.A., Douglas, P.S., Cook, N.L., et al. Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 60 (2012), 569–580.
140. 140 http://www.uspreventiveservicestaskforce.org/us.